Literature DB >> 22430880

Diabetes: Should we treat infection or inflammation to prevent T2DM?

Outi Vaarala, Hannele Yki-Järvinen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22430880     DOI： 10.1038/nrendo.2012.31

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  9 in total

Review 1.  Macrophages, inflammation, and insulin resistance.

Authors:  Jerrold M Olefsky; Christopher K Glass
Journal:  Annu Rev Physiol       Date:  2010       Impact factor: 19.318

Review 2.  Role of IL-1beta in type 2 diabetes.

Authors:  Charles A Dinarello; Marc Y Donath; Thomas Mandrup-Poulsen
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-08       Impact factor: 3.243

3.  NF-kappaB- and C/EBPbeta-driven interleukin-1beta gene expression and PAK1-mediated caspase-1 activation play essential roles in interleukin-1beta release from Helicobacter pylori lipopolysaccharide-stimulated macrophages.

Authors:  Chaitali Basak; Sushil Kumar Pathak; Asima Bhattacharyya; Debabrata Mandal; Shresh Pathak; Manikuntala Kundu
Journal:  J Biol Chem       Date:  2004-11-23       Impact factor: 5.157

4.  The effect of H. pylori eradication on meal-associated changes in plasma ghrelin and leptin.

Authors:  Fritz Francois; Jatin Roper; Neal Joseph; Zhiheng Pei; Aditi Chhada; Joshua R Shak; Asalia Z Olivares de Perez; Guillermo I Perez-Perez; Martin J Blaser
Journal:  BMC Gastroenterol       Date:  2011-04-14       Impact factor: 3.067

5.  Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation.

Authors:  Mariann I Lassenius; Kirsi H Pietiläinen; Kati Kaartinen; Pirkko J Pussinen; Jaana Syrjänen; Carol Forsblom; Ilkka Pörsti; Aila Rissanen; Jaakko Kaprio; Jukka Mustonen; Per-Henrik Groop; Markku Lehto
Journal:  Diabetes Care       Date:  2011-06-02       Impact factor: 19.112

6.  Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort study.

Authors:  Christian Herder; Jens Baumert; Astrid Zierer; Michael Roden; Christa Meisinger; Mahir Karakas; Lloyd Chambless; Wolfgang Rathmann; Annette Peters; Wolfgang Koenig; Barbara Thorand
Journal:  PLoS One       Date:  2011-06-06       Impact factor: 3.240

7.  Salsalate attenuates free fatty acid-induced microvascular and metabolic insulin resistance in humans.

Authors:  Weidong Chai; Jia Liu; Linda A Jahn; Dale E Fowler; Eugene J Barrett; Zhenqi Liu
Journal:  Diabetes Care       Date:  2011-05-26       Impact factor: 19.112

8.  Helicobacter pylori infection is associated with an increased rate of diabetes.

Authors:  Christie Y Jeon; Mary N Haan; Caroline Cheng; Erin R Clayton; Elizabeth R Mayeda; Joshua W Miller; Allison E Aiello
Journal:  Diabetes Care       Date:  2012-01-25       Impact factor: 19.112

9.  Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes.

Authors:  Claus M Larsen; Mirjam Faulenbach; Allan Vaag; Jan A Ehses; Marc Y Donath; Thomas Mandrup-Poulsen
Journal:  Diabetes Care       Date:  2009-06-19       Impact factor: 19.112
  9 in total
  10 in total

Review 1.  Helicobacter pylori infection and diabetes: is it a myth or fact?

Authors:  Cong He; Zhen Yang; Nong-Hua Lu
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

Review 2.  Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State.

Authors:  Maya Fayfman; Francisco J Pasquel; Guillermo E Umpierrez
Journal:  Med Clin North Am       Date:  2017-05       Impact factor: 5.456

3.  Impact of weight loss on oxidative stress and inflammatory cytokines in obese type 2 diabetic patients.

Authors:  Shehab M Abd El-Kader; Mohammed H Saiem Al-Dahr
Journal:  Afr Health Sci       Date:  2016-09       Impact factor: 0.927

4.  Potential effect of chronic Helicobacter pylori infection on glucose metabolism of Mongolian gerbils.

Authors:  Zhen Yang; Wei Li; Cong He; Chuan Xie; Yin Zhu; Nong-Hua Lu
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

Review 5.  Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease.

Authors:  Meng Li; Zhe Shen; You-Ming Li
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

6.  Function of NLRP3 in the Pathogenesis and Development of Diabetic Nephropathy.

Authors:  Ying Fu; Nannan Wu; Dong Zhao
Journal:  Med Sci Monit       Date:  2017-08-11

Review 7.  Coinfections and comorbidities in African health systems: At the interface of infectious and noninfectious diseases.

Authors:  Derick Nii Mensah Osakunor; David Moinina Sengeh; Francisca Mutapi
Journal:  PLoS Negl Trop Dis       Date:  2018-09-20

8.  Diabetic patients infected with helicobacter pylori have a higher Insulin Resistance Degree.

Authors:  Jamshid Vafaeimanesh; Mohammad Bagherzadeh; Akram Heidari; Fatemeh Motii; Mahmoud Parham
Journal:  Caspian J Intern Med       Date:  2014

Review 9.  Inhibitory G proteins and their receptors: emerging therapeutic targets for obesity and diabetes.

Authors:  Michelle E Kimple; Joshua C Neuman; Amelia K Linnemann; Patrick J Casey
Journal:  Exp Mol Med       Date:  2014-06-20       Impact factor: 8.718

Review 10.  Cardiovascular disease and type 2 diabetes in evolutionary perspective: a critical role for helminths?

Authors:  Michael D Gurven; Benjamin C Trumble; Jonathan Stieglitz; Aaron D Blackwell; David E Michalik; Caleb E Finch; Hillard S Kaplan
Journal:  Evol Med Public Health       Date:  2016-09-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.